Published in Infect Immun on December 01, 1988
Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun (1991) 2.46
Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun (2010) 1.94
Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog (2012) 1.49
Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am J Pathol (1990) 1.48
Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun (1998) 1.38
Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev (1995) 1.32
Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun (1991) 1.12
Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction. Infect Immun (2011) 1.00
Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect Immun (1993) 0.96
Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin. Infect Immun (1992) 0.95
Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect Immun (1993) 0.93
Growth inhibition of Candida albicans by interleukin-2-activated splenocytes. Infect Immun (1992) 0.93
Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect Immun (1992) 0.92
Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions. Infect Immun (1989) 0.87
Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice. Am J Pathol (1995) 0.83
Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis. Infect Immun (1996) 0.83
Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections. J Immunol (2012) 0.80
Adherence of Candida albicans to tissues from mice with genetic immunodeficiencies. Infect Immun (1991) 0.80
IL-12 and related cytokines: function and regulatory implications in Candida albicans infection. Clin Dev Immunol (2010) 0.78
Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases. Infect Immun (2014) 0.77
Low-level laser therapy stimulates the oxidative burst in human neutrophils and increases their fungicidal capacity. J Biophotonics (2016) 0.75
A severe combined immunodeficiency mutation in the mouse. Nature (1983) 13.99
Interaction of Candida albicans with human leukocytes and serum. J Bacteriol (1969) 9.19
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol (1985) 2.80
Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest (1978) 2.72
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc (1976) 2.07
The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc (1976) 1.87
Immune responses to Candida albicans in genetically distinct mice. Infect Immun (1982) 1.78
Passive immunization of mice against Candida albicans. Sabouraudia (1968) 1.73
Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect Immun (1979) 1.67
Immunity to Candida albicans. Microbiol Rev (1980) 1.66
Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.54
Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans. Infect Immun (1980) 1.48
Role of complement during experimental Candida infection in mice. Infect Immun (1971) 1.46
Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol (1980) 1.44
Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations. J Infect Dis (1972) 1.40
Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro. J Clin Invest (1981) 1.38
Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr (1969) 1.37
Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. J Immunol (1976) 1.35
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infect Immun (1978) 1.31
Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge. Infect Immun (1978) 1.31
Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. Immunology (1977) 1.27
Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol (1987) 1.27
Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. J Infect Dis (1988) 1.22
An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19
Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect Immun (1974) 1.15
Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice. Infect Immun (1981) 1.13
Esophageal, gastric, and intestinal candidiasis. Am J Med (1984) 1.12
Cellular elements in the resistance to candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol Immunol (1977) 1.09
Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun (1988) 1.03
Characterization of B lymphocyte lineage progenitor cells from mice with severe combined immune deficiency disease (SCID) made possible by long term culture. J Immunol (1987) 1.03
Immunoglobulin heavy chain gene diversification in the long-term bone marrow culture of normal mice and mice with severe combined immunodeficiency. Eur J Immunol (1987) 0.99
Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics (1987) 0.99
Systemic candidosis in silica-treated athymic and euthymic mice. Infect Immun (1983) 0.94
Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats. Infect Immun (1978) 0.94
Systemic candidosis in germfree, flora-defined and conventional nude and thymus-bearing mice. J Reticuloendothel Soc (1981) 0.90
An immune factor in baboon anti-candida serum. Sabouraudia (1970) 0.89
Immunity to experimental renal candidiasis in rats. Infect Immun (1978) 0.89
Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines. Cell Immunol (1986) 0.77
Studies of experimental candidiasis in T-cell-deficient mice. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.77
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol (1978) 4.93
CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 4.04
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med (1990) 3.78
A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol (1991) 3.23
Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med (1991) 3.21
Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med (1990) 3.05
Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein. Nature (1985) 2.97
Suppression of immunoglobulin G synthesis as a result of antibody-mediated suppression of immunoglobulin M synthesis in chickens. Proc Natl Acad Sci U S A (1970) 2.93
Antigens displayed on murine B lymphocyte precursors. J Immunol (1981) 2.91
Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol (1989) 2.64
Identification of stromal cell products that interact with pre-B cells. J Cell Biol (1996) 2.46
Development and distribution of immunoglobulin-containing cells in the chicken. An immunofluorescent analysis using purified antibodies to mu, gamma and light chains. J Immunol (1971) 2.46
The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol (1990) 2.32
Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med (1992) 2.30
B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proc Natl Acad Sci U S A (1988) 2.05
Restriction of surface immunoglobulin determinants to lymphocytes of the plasma cell line. J Immunol (1971) 2.01
Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol (2001) 1.91
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent. J Exp Med (1976) 1.86
Cell-specific heterogeneity in sensitivity of phosphatidylinositol-anchored membrane antigens to release by phospholipase C. J Immunol Methods (1988) 1.85
Monoclonal rat antibodies to murine IgM determinants. J Immunol Methods (1981) 1.75
The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice. J Exp Med (1979) 1.68
Formation of eosinophilic-like granulocytic colonies by mouse bone marrow cells in vitro. J Cell Physiol (1974) 1.68
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. J Exp Med (1977) 1.67
Relationships between B-lineage lymphocytes and stromal cells in long-term bone marrow cultures. Eur J Immunol (1987) 1.64
Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med (1995) 1.62
Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) (1994) 1.54
A two-stage model for development of antibody-producing cells. Clin Exp Immunol (1972) 1.53
Suppression of B lymphopoiesis during normal pregnancy. J Exp Med (1993) 1.48
Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood (2000) 1.46
CD19+ pro-B cells can give rise to dendritic cells in vitro. J Immunol (1998) 1.45
Formation of B lymphocytes in fetal and adult life. Adv Immunol (1981) 1.43
Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events. Immunity (2000) 1.42
Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci U S A (1994) 1.42
Preferential but nonexclusive expression of macromolecular antigens on B-lineage cells. Immunol Rev (1982) 1.41
The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol (1998) 1.40
Beta transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med (1987) 1.39
Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice. J Exp Med (1977) 1.39
Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A (1999) 1.39
Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood (2001) 1.38
Careers in immunology: the new reality. Nat Immunol (2001) 1.38
Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells. J Immunol (1984) 1.34
Sequential expression of germ line genes in development of immunoglobulin class diversity. Fed Proc (1975) 1.31
Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol (1995) 1.31
Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation (2001) 1.30
Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors. Eur J Immunol (1988) 1.30
CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol (1998) 1.28
Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol (1992) 1.27
Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol (1995) 1.25
IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol (1990) 1.24
Characterization of murine bone marrow and spleen-derived stromal cells: analysis of leukocyte marker and growth factor mRNA transcript levels. Blood (1989) 1.22
Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol (1999) 1.17
Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J Comp Pathol (1992) 1.16
Type I interferons and limitin: a comparison of structures, receptors, and functions. Cytokine Growth Factor Rev (2001) 1.15
Purification and characterization of a major cytoplasmic antigen of Candida albicans. Infect Immun (1981) 1.15
Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat Med (2000) 1.14
Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol (1994) 1.14
Independent control of immunoglobulin heavy and light chain expression in a murine pre-B-cell line. Nature (1981) 1.13
Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol (1993) 1.13
Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. Pacing Clin Electrophysiol (1997) 1.13
Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun (1991) 1.12
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function. Rev Infect Dis (1983) 1.12
Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. J Immunol (1991) 1.11
Demonstration of neural cell adhesion molecules on stromal cells that support lymphopoiesis. Leukemia (1988) 1.10
Immunoglobulin A: site and sequence of expression in developing chicks. Science (1973) 1.09
Characterization of murine colony-forming B cells. I. Distribution, resistance to anti-immunoglobulin antibodies, and expression of Ia antigens. J Immunol (1978) 1.09
Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J Immunol (1999) 1.06
Molecular mapping of signals in the Qa-2 antigen required for attachment of the phosphatidylinositol membrane anchor. Proc Natl Acad Sci U S A (1988) 1.05
Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci U S A (2001) 1.05
Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood (1999) 1.05
Phenotypic and functional characterization of murine B lymphocyte precursors isolated from fetal and adult tissues. J Immunol (1983) 1.04
Serum proteins and lymphoid tissues in germ-free mice fed a chemically defined, water soluble, low molecular weight diet. Immunology (1970) 1.03
Characterization of B lymphocyte lineage progenitor cells from mice with severe combined immune deficiency disease (SCID) made possible by long term culture. J Immunol (1987) 1.03
Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia. J Infect Dis (1983) 1.03
Quantitation of antibody to Candida mannan by enzyme-linked immunosorbent assay. J Lab Clin Med (1983) 1.02
Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm (2000) 1.02
Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol (1981) 1.00
Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol (1994) 1.00
Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J Exp Med (1994) 1.00
Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation (1993) 0.98
B29 gene products complex with immunoglobulins on B lymphocytes. Proc Natl Acad Sci U S A (1992) 0.98
Cellular interactions affecting the maturation of murine B lymphocyte precursors in vitro. J Immunol (1981) 0.97
Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice. Proc Natl Acad Sci U S A (1979) 0.96
Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular characterization. Eur J Immunol (1990) 0.96
Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. J Immunol (1980) 0.96
Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice. J Immunol (1988) 0.95
A new cell adhesion mechanism involving hyaluronate and CD44. Curr Top Microbiol Immunol (1990) 0.95
Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J Parasitol (1994) 0.95
Characterization of murine colony-forming B cells. II. Limits to in vitro maturation, Lyb-2 expression, resolution of IgD+ subsets, and further population analysis. J Immunol (1980) 0.94
B lymphocyte development. Fed Proc (1985) 0.94
Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood (1996) 0.94
Apophysomyces elegans infection in a renal transplant recipient. Am J Kidney Dis (1995) 0.93
Precursors of murine B lymphocytes. Physical and functional characterization, and distinctions from myeloid stem cells. J Exp Med (1981) 0.93
B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation. J Immunol (1983) 0.93
Cycling of peripheral blood and marrow lymphocytes in cyclic neutropenia. Proc Natl Acad Sci U S A (1983) 0.92